L. Brichta

发表

In vitro and ex vivo evaluation of second‐generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy

Peter Claus, Ingmar Blümcke, Rolf Buslei, 2006, Journal of neurochemistry.

Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy

S. Grellscheid, B. Wirth, M. Jędrzejowska, 2008, Human Genetics.

Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis

Jennifer M. Rust, P. Greengard, K. Dolinski, 2020, Neuron.

Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis

P. Greengard, O. Troyanskaya, P. Hof, 2018, Neuron.

An ~140-kb deletion associated with feline spinal muscular atrophy implies an essential LIX1 function for motor neuron survival

R. Agarwala, A. Schäffer, S. O’Brien, 2006 .

An approximately 140-kb deletion associated with feline spinal muscular atrophy implies an essential LIX1 function for motor neuron survival.

R. Agarwala, A. Schäffer, S. O’Brien, 2006, Genome research.

Identification of Neurodegenerative Factors Using Translatome-Regulatory Network Analysis

Andrea Califano, Paul Greengard, Mariano J. Alvarez, 2015, Nature Neuroscience.

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.

B. Wirth, G. Dacremont, R. Wanders, 2010, Human molecular genetics.

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number

B. Wirth, Hanns Lochmüller, R. Heller, 2006, Human Genetics.

function for motor neuron survival LIX1 implies an essential An ~140-kb deletion associated with feline spinal muscular atrophy

A. Schäffer, W. Murphy, B. Wirth, 2006 .

Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems

Marc Flajolet, Paul Greengard, P. Greengard, 2013, Trends in Neurosciences.

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update

P. Greengard, L. Brichta, 2014, Front. Neuroanat..

Pronounced Conformational Changes following Agonist Activation of the M3 Muscarinic Acetylcholine Receptor*

J. Wess, K. Jacobson, F. Hamdan, 2005, Journal of Biological Chemistry.

Loss of SATB1 Induces a p21 Dependent Cellular Senescence Phenotype in Dopaminergic Neurons

P. Greengard, G. Ciceri, J. Shim, 2018, bioRxiv.

Loss of SATB1 Induces p21-Dependent Cellular Senescence in Post-mitotic Dopaminergic Neurons.

P. Greengard, G. Ciceri, J. Shim, 2019, Cell stem cell.

Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata

L. Brichta, R. Sidbury, Cheryl B Bayart, 2017, Journal of the American Academy of Dermatology.

Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain

Steven M. Graves, P. Greengard, D. Surmeier, 2019, Nature Neuroscience.

Molecular genetic investigations of histone deacetylase inhibitors as potential neurotherapeutics for autosomal recessive proximal spinal muscular atrophy (SMA)

L. Brichta, 2006 .

Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation

E. Boscolo, L. Brichta, Yuqi Cai, 2019, Arteriosclerosis, thrombosis, and vascular biology.

Spinal muscular atrophy: from gene to therapy.

Eric Hahnen, B. Wirth, E. Hahnen, 2006, Seminars in pediatric neurology.

In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate

B. Wirth, T. Klockgether, L. Brichta, 2006, Annals of neurology.

The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells

B. Wirth, E. Hahnen, L. Brichta, 2006, Human Genetics.

Spinal muscular atrophy and therapeutic prospects.

B. Wirth, E. Hahnen, L. Brichta, 2006, Progress in molecular and subcellular biology.

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.

Y. Hofmann, B. Wirth, I. Blumcke, 2003, Human molecular genetics.

CK1δ over-expressing mice display ADHD-like behaviors, frontostriatal neuronal abnormalities and altered expressions of ADHD-candidate genes

P. Greengard, K. Uryu, M. Flajolet, 2018, Molecular Psychiatry.

Experience-dependent translational state defined by cell type-specific ribosome profiling

Nicholas T. Ingolia, P. Greengard, T. Dawson, 2017, bioRxiv.

Role of the Astroglial Glutamate Exchanger xCT in Ventral Hippocampus in Resilience to Stress

P. Greengard, B. McEwen, R. Neve, 2017, Neuron.

Topical sirolimus: Difference between compounded preparations and commercial oral solution

L. Brichta, James G Carver, Cynthia Marie Carver DeKlotz, 2021, Pediatric dermatology.

Use of Tofacitinib, 2%, Ointment for Periorbital Discoid Lupus Erythematosus.

D. Mazori, L. Brichta, J. Merola, 2021, JAMA dermatology.

Transient Activation of GABAB Receptors Suppresses SK Channel Currents in Substantia Nigra Pars Compacta Dopaminergic Neurons

P. Greengard, D. Surmeier, J. Goldberg, 2016, PloS one.

Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain

P. Greengard, D. Surmeier, D. Krainc, 2019, Nature Neuroscience.